The new SARS-CoV-2 Omicron variant, identified for the first time November 26th, 2021, has been designated by World Health Organization, WHO, as variant of concern. It has a large number of mutations, specially concerning are 30 mutations in the Spike protein. WHO has informed that preliminary data suggests the variant has higher transmissibility than other variants of concern. First cases were detected in South Africa, but at least other 12 countries have already identified positive cases.
VIRCELL S.L is glad to inform that the whole range of molecular diagnostic products developed for SARS-CoV-2 diagnostic can be use accurately for this purpose, regardless of the type of virus variants. Our range of molecular diagnostic products cover all possible needs in the clinical laboratories.
Please feel free to contact your Area Manager for any inquiry you should have.